4,5-Difluoro-2-(1H-pyrrol-1-yl)aniline, 98%, 250mg

1-Boc-L-Pyroglutamic acid ethyl ester, 97.0%, 100g

(R)-2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)pyrrolidin-2-yl)acetic acid, 95.0%, 5g

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 30 m, Ø-Innen 0,53 mm, Filmd. 0,50 µm, 1 Stück

[1-(N-Boc-aminomethyl)-cyclohexyl]-acetic acid, 97.0%, 25g

(S)-1-(2,6-Difluorophenyl)ethanamine hydrochloride, 95.0%, 250mg

N-(3-methoxybenzoyl)glycine, 95.0%, 1g

1,3-Dimethyl-5-iodopyrazole, 95.0%, 500mg

2-Methyl-6-phenylpyridine, 95.0%, 1g

8-Ethyl-7-fluoro-3-(methoxymethoxy)naphthalen-1-ol, 98%, 100mg

Tert-butyl(2r)-2-carbamoylazetidine-1-carboxylate, 98%, 250mg

4-(Piperazin-1-yl)cyclohexanecarboxylic acid ethyl ester, 95%, 250mg

5-(2,3-dihydro-1,4-benzodioxin-2-yl)-1,3,4-oxadiazol-2-amine, 95.0%, 1g